Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
复制标题
DOI：
10.1093/annonc/mdx222
复制
发表时间：
2017-07-01
影响因子：
50.5
通讯作者：
Peters, S.
中科院分区：
文献类型：
--
作者：
Postmus, P. E.;Kerr, K. M.;Peters, S.
肺癌是全球癌症死亡的主要原因，2012年新增确诊病例180万例，占所有确诊癌症的13%[1]。尽管西方世界的人数持续小幅下降，但全球的这一数字仍在上升。全球统计数据估计，15%的男性肺癌和53%的女性肺癌不是由吸烟引起的，总体占25%[2]。
Lung cancer is the leading cause of cancer mortality worldwide with 1.8 million newly diagnosed cases, or 13% of all cancers diagnosed, in 2012 [1]. The worldwide numbers are still rising despite an ongoing small decline in the Western world. Global statistics estimate that 15% of lung cancers in men and 53% in women are not attributable to smoking, overall accounting for 25%[2].